If you have any departmental or Trust news you'd like to share, please get in touch.
- Details
Geneva, Switzerland – Masimo announced the findings of an abstract presented at Euroanaesthesia in Geneva, Switzerland.
In the study, researchers at University Medical Center Groningen, Netherlands compared original and Next Generation versions of Masimo Patient State Index (PSi, a processed EEG parameter related to the effect of anesthetic agents) during Masimo SedLine® brain function monitoring of patients under propofol and sevoflurane anesthesia.1
SedLine brain function monitoring features four simultaneous EEG leads to enable continuous assessment of both sides of the brain, four EEG waveforms, a Density Spectral Array (DSA; an easy-to-interpret, high-resolution display of bi-hemispheric activity and EEG power), and PSi. Next Generation SedLine enhances PSi to make it less susceptible to electromyographic (EMG) interference and to improve its performance in low-power EEG cases.
In the study, Dr. Kuizenga and colleagues sought to compare the original and Next Generation PSi algorithms, referred to as PSi-1 and PSi-2, respectively, as they correlated with propofol and sevoflurane drug concentrations and with the Modified Observers Assessment of Alertness and Sedation (MOAAS) scale. They also sought to assess the influence of 2 and 4 ng/mL effect-site concentrations of remifentanil on the performance of the two algorithms.
The researchers enrolled 36 healthy volunteers, stratified by age, and assigned them randomly to a sequence of four sessions of anesthesia. In one session, propofol was administered in a series of graded steps; in the second, sevoflurane was similarly administered; in the third and fourth, the two concentrations of remifentanil were also administered. During each step of each session, after a twelve-minute delay for equilibration, MOAAS was tested and a blood sample was taken to measure drug concentrations. EEG was collected using Masimo Root® with SedLine, from which time-synchronized PSi-1 and PSi-2 values were later extracted. The researchers then plotted MOAAS, drug concentration, PSi-1, and PSi-2 values over time.
The researchers found that when charted against drug concentrations, PSi-2 showed "reduced population variability and improved baseline stability" compared to PSi-1. When charted against MOAAS, PSi-2 had "lower interindividual variability" than PSi-1. They also noted that "Both PSis distinguish MOAAS 5, 4, and 3 better during propofol anesthesia compared to sevoflurane. This difference disappears when adding remifentanil."
The investigators concluded that "PSi-2 [Next Generation SedLine PSi] has enhanced signal stability and a better description of the dose-response relationship. PSi-2 has therefore improved capacity as a pharmacodynamic monitor of anesthesia compared to PSi-1."
Next Generation SedLine has not received 510(k) clearance and is not available for sale in the United States.
@MasimoInnovates || #Masimo
- Details
A leading manufacturer of biomedical test equipment has unveiled its latest innovation in defibrillator analysers.
Rigel Medical has launched the UniPulse 400, an easy-to-use defibrillator analyser with built-in pacer functionality designed to provide a comprehensive solution for quick and efficient testing.
Compatible with all defibrillators, the UniPulse 400 is built to display highly accurate results in exhaustive detail.
A compact ergonomic design and rechargeable battery make the UniPulse 400 the ideal solution for busy engineers testing multiple machines on the go, while Rigel’s Med-eBase software allows results to be downloaded quickly via USB.
The UniPulse 400 also features an easy-to-use interface with intuitive navigation and dedicated fast keys to ensure a seamless user experience – with an LCD screen displaying clear and detailed results.
Michael Walton, category manager at Rigel Medical, said: “The UniPulse 400 is our most comprehensive and advanced defibrillator analyser to date.
“We know time and efficiency is a key issue for our customers – and we’ve designed the UniPulse with this in mind.
“Features like instant digital results transfer and user-friendly navigation allow busy engineers to work efficiently without compromising on accuracy.”
Rigel, which is part of Seaward Group, is one of the longest established names in the medical industry, dating back to the 1970s when it created the world’s first electrical safety analyser.
The company also offers a wealth of free training and support material including on-demand webinars to help engineers get to grips with their devices.
To find out more, please download your free guide to defibrillation and transcutaneous pacing.
- Details
CITREX H5 is an all-in-one solution enabling medical technicians, independent service providers, anaesthetists and ventilator manufacturers to measure and calibrate their devices. Precision and accuracy are the most important characteristics because the user has to be able to rely on the readings with regard to patient health.
Clearly arranged and customisable
Within its class the CITREX H5 not only leads the field in this respect but is also impressive on account of its intuitive and customisable user interface. With the newly developed user interface and large 4.3" screen you always have a perfect view of the settings and readings you are looking for: depending on requirements, the measurable ventilation parameters, of which there are 26 in total, can also be arranged or highlighted to suit personal preferences. Thanks to a long-life rechargeable battery and a practical format the CITREX H5 can also accompany you wherever you go.
Always up to date with Wi-Fi
The software of the CITREX H5 is actively subjected to further development by IMT Analytics AG throughout the service life of the product. With updates that are installed simply and quickly via Wi-Fi the device always remains up to date and thanks to apps it also has features that make your work much easier. IMT Analytics’ customer focus ensures that functions offered will continue to serve customers' needs in the future.
- Large 4.3" multi-touch display with 800 x 480 pixels
- Intuitive graphical user interface
- Bidirectional measurement
- Expanded profile management
- Flow and pressure trigger settings
- Up to 17 gas standards and 26 ventilation parameters
- On-screen measurement, read parameters in real time
- USB, RS-232, Ethernet, CAN, external trigger input, Analogue out and Wi-Fi interfaces
https://www.imtanalytics.com/Analyser/CITREX_H5
- Details
Service plus from seca
Warranty of up to 8 years
Secure up to eight years of operational piece of mind with the seca 8 year warranty.
To qualify for this additional warranty, please follow the below:
- Scales must be purchased direct from seca
- 8 year warranty is applicable on our seca wireless class III medical scales – EMR ready!
- Sign up for a seca service / calibration contract
- https://uk.secashop.com/services/calibration-service
From 2019, all class III digital scales are supplied with a 4 year warranty, as standard.
The medical line price list highlights the new warranty per device. The prices within this document are full list price, however, your trust is entitled to large discounts – contact us for details.
seca integration solutions
In the constantly growing EMR market, we already offer solutions for many EPR’s. seca understands the integration process with our new bi-directional connectivity which ensures maximum patient safety by reducing transcription errors, whilst saving valuable clinical time.
The ID of clinical staff and patients are captured with a barcode scanner connected to the scale, indicator lights signal the validity of user and patient data. Measurements are then transmitted via the hospital network directly to the patients EPR.
Our system is already fully integrated with Cerner, Epic, Allscripts, Meditech and Elekta. We have a dedicated technical team, who are available to develop a HL7 interface for other EPR systems.
Many NHS hospitals have already started integration projects to connect seca wireless scales to their EPR, as they recognise the benefit of direct weight and height transmission.
https://uk.secashop.com/innovations/seca-integration
Should you require any further information regarding warranty, service/calibration contracts, direct purchasing or integration requirements, please see below for our contact details:
Your seca team
This email address is being protected from spambots. You need JavaScript enabled to view it.
0121 643 93 49
- Details
A MANUFACTURER of specialist biomedical testing equipment has launched a free mobile phone app to help clinical engineers performing electrical safety tests in the field.
Built as a companion to the Rigel 288+ electrical safety analyser, the Downloader app allows field service engineers using the device to create and upload digital test records.
Users can remotely attach their test records to a computerised maintenance management system (CMMS) or send them to a central database.
The 288+ is an electrical safety analyser designed to perform routine tests on medical electrical equipment.
These tests play a vital role as they highlight faults with medical equipment in hospitals and healthcare facilities, picking up on issues which can compromise patient safety.
Engineers are required to carry out the tests as part of a planned preventative maintenance schedule, however traceability and the time consuming process of storing test records to asset maintenance software can pose a challenge.
Michael Walton, senior application engineer at Rigel Medical, said: “Time constraints are a key challenge for our customers – and Downloader is designed to help them complete tests quicker and more efficiently.
“The app allows technicians to attach a test record to their preferred system via email, minimising time spent on site and streamlining the reporting process.”
The Downloader app is available to download now from Google Play and is compatible with Rigel 288+ devices.
Rigel, which is part of Seaward Group, is one of the longest established names in the medical industry, dating back to the 1970s when it created the world’s first electrical safety analyser.
It now employs 160 people worldwide as well as supporting a global network of distributors across Europe, USA, the Middle East and Southeast Asia.
